Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00084370
What this trial is testing

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierOvarian Cancer
University of Alabama at Birmingham
Not applicableAvailableNCT06761976
What this trial is testing

Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation

Who this might be right for
Advanced Non-small Cell Lung CancerCancer
Bayer
Early research (Phase 1)Study completedNCT03781362
What this trial is testing

Study of CPI-100 in Patients With Advanced Tumors

Who this might be right for
Advanced Tumors
Coordination Pharmaceuticals, Inc. 36
Not applicableStudy completedNCT04189003
What this trial is testing

Molecular Signatures of HPV+ ORL Cancers (OROPAP)

Who this might be right for
Oropharyngeal CancerHuman Papillomavirus-Related Carcinoma
Assistance Publique - Hôpitaux de Paris 66
Testing effectiveness (Phase 2)Looking for participantsNCT05413473
What this trial is testing

Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)

Who this might be right for
Cancer
AHS Cancer Control Alberta 99
Early research (Phase 1)Study completedNCT00356460
What this trial is testing

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Who this might be right for
Carcinoma, Renal CellMelanoma
Genzyme, a Sanofi Company 29
Post-approval studies (Phase 4)Study completedNCT02081469
What this trial is testing

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

Who this might be right for
Hepatitis B, ChronicTumor
Chang Gung Memorial Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01973660
What this trial is testing

PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 151
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06462079
What this trial is testing

Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases

Who this might be right for
Brain Metastasis
Guangzhou Medical University 43
Large-scale testing (Phase 3)Study completedNCT03185013
What this trial is testing

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Who this might be right for
Cervical DysplasiaCervical High Grade Squamous Intraepithelial LesionHSIL
Inovio Pharmaceuticals 201
Testing effectiveness (Phase 2)UnknownNCT03823079
What this trial is testing

Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia

Who this might be right for
Recurrent Colorectal CarcinomaThrombopenia
Fudan University 50
Early research (Phase 1)Active Not RecruitingNCT05362773
What this trial is testing

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics 130
Not applicableUnknownNCT03680183
What this trial is testing

Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)

Who this might be right for
Non Small Cell Lung CancerHepatitis B
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 300
Early research (Phase 1)Study completedNCT04126707
What this trial is testing

The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans

Who this might be right for
Chronic Myeloid Leukemia (CML)
Ascentage Pharma Group Inc. 6
Not applicableUnknownNCT01972867
What this trial is testing

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

Who this might be right for
Prostate Cancer
Angiodynamics, Inc. 6
Not applicableStudy completedNCT00006444
What this trial is testing

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Who this might be right for
HIV InfectionsPapilloma
National Institute of Allergy and Infectious Diseases (NIAID) 160
Early research (Phase 1)Looking for participantsNCT06241898
What this trial is testing

A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Bliss Biopharmaceutical (Hangzhou) Co., Ltd 300
Testing effectiveness (Phase 2)Study completedNCT05659563
What this trial is testing

Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%

Who this might be right for
Breast CancerBreast Cancer, Early-Onset
MedSIR 92
Early research (Phase 1)Looking for participantsNCT07252414
What this trial is testing

GenSci143 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd. 180
Early research (Phase 1)Study completedNCT02519452
What this trial is testing

Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 120
Next Page